Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women

What Was Tested

Researchers studied Parathyroid Hormone (PTH 1-84) in the context of osteoporosis and bone density in this randomized controlled trial publication.

The purpose of the present prospective, randomized, controlled study was to evaluate the effect of PTH 1-84 on the course of pelvic fracture-healing and functional outcome in postmenopausal women.

Who Took Part

PubMed indexes the participants as older adults and people over 80, women only.

Sixty-five patients had a dual x-ray absorptiometry scan, radiographs, and a computed tomography scan to document pelvic fractures.

How the Study Was Run

The design is described as randomized.

Because people in this Parathyroid Hormone (PTH 1-84) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Computed tomography scans were repeated every fourth week until radiographic evidence of cortical bridging at the fracture site was confirmed.

Functional outcome was assessed with use of a visual analog scale for pain and a Timed "Up and Go" test.

What Was Measured

PubMed files the paper under topics including Absorptiometry, Photon, Bone Density, Fracture Healing, Fractures, Bone, Geriatric Assessment, Osteoporosis, Postmenopausal and Parathyroid Hormone.

What This Means in Plain Language

The paper is a randomized study of Parathyroid Hormone (PTH 1-84) in people with osteoporosis and bone density.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2011 (The Journal of bone and joint surgery. American volume), a journal based in United States.

More context: the Parathyroid Hormone (PTH 1-84) compound page, Osteoporosis and bone density research.